The selloff looks dramatic until you zoom out and see it's just a pullback within a parabolic two-month rally that's up nearly 50%. That's the chart story: a Doji reversal day suggests indecision, but the trend is still overwhelmingly up. The real question is whether this dip is a buying opportunity or the start of a deeper correction.

The math gives us a mixed bag. IV at 33% is elevated but not screaming, pricing in a decent expected move. The problem is the safety score of 8/9—this is a high-beta name, not a stable blue-chip, so that 'safety' feels like a mirage.

For a credit put spread, we need the stock to hold above a key support level. I'm eyeing the $122-$125 zone as a logical floor; it's a prior consolidation area and about 4-6% below the current price. That's where we can sell a put.

But the risk-first skeptic in me is loud here: a 7% drop on high momentum is a warning shot, not an invitation. The structure needs to be tight and defined. A narrow $2.

50 wide spread keeps max loss manageable and lets us get a decent credit-to-width ratio. Selling the $125 put and buying the $122. 50 put, 35 days out, should net around $0.

70. That's a 0. 28 ratio, just clearing our 0.

25 floor. Why that matters: a narrow spread with a decent credit means we're getting paid for the risk of the stock falling another 4%, but our max loss is capped at $180 per spread. It's a bet that the uptrend's momentum absorbs this shock.

I'm leaning OPEN, but it's a cautious one—size small, because if that $122 support breaks, the next stop could be much lower. This isn't a 'set and forget' trade; it's a tactical play on a high-flyer catching its breath.